|   | 
Pemetrexed
                            - 英文名称:Pemetrexed
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10569
- cas:357166-29-1
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-10-31
产品详请
            | 产地 | 进口 | 
| 品牌 | WYTSCI | 
| 货号 | WT-AY-B10569 | 
| 用途 | 科研检测 | 
| 英文名称 | Pemetrexed | 
| 包装规格 | 1MG | 
| CAS编号 | 357166-29-1 | 
| 别名 | Pemetrexed | 
| 纯度 | 98+% | 
| 分子式 | |
| 是否进口 | 是 | 
                纯度:98% by TLC and HPLC,;NMR (Conforms)
分子式:C20H19N5O6 ? 2Na ? 7H2O
分子量:597.49
溶剂:Water (100 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):Antifolate; antitumor agent
Function / Pharmacology:Pemetrexed is a multi-targeted antifolate with antitumor activity. It potently inhibits folate-dependent enzymes involved in both purine and pyrimidine synthesis including thymidylate synthase (Ki = 109 nM), dihydrofolate reductase (Ki = 7 nM), glycinamide ribonucleotide formyltransferase (Ki = 9.3 μM), and aminoimidazole carboxamide ribonucleotide formyltransferase (Ki = 3.6 μM).1 A clinically useful anticancer agent.2 Indirectly activates the metabolic kinase AMPK and consequently influences the mTORC1 pathway in human carcinomas.3 Activation of AMPK is associated with pemetrexed resistance.4 Induces G0/G1-phase cell cycle arrest in esophageal squamous cell carcinoma cells.5
            
        分子式:C20H19N5O6 ? 2Na ? 7H2O
分子量:597.49
溶剂:Water (100 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):Antifolate; antitumor agent
Function / Pharmacology:Pemetrexed is a multi-targeted antifolate with antitumor activity. It potently inhibits folate-dependent enzymes involved in both purine and pyrimidine synthesis including thymidylate synthase (Ki = 109 nM), dihydrofolate reductase (Ki = 7 nM), glycinamide ribonucleotide formyltransferase (Ki = 9.3 μM), and aminoimidazole carboxamide ribonucleotide formyltransferase (Ki = 3.6 μM).1 A clinically useful anticancer agent.2 Indirectly activates the metabolic kinase AMPK and consequently influences the mTORC1 pathway in human carcinomas.3 Activation of AMPK is associated with pemetrexed resistance.4 Induces G0/G1-phase cell cycle arrest in esophageal squamous cell carcinoma cells.5

 
     
            
            
            
              
             

